MGF
A mechanically induced IGF-1 splice-variant peptide studied in preclinical muscle and cellular research models.
Molecular Profile
- Type
- Synthetic peptide (IGF-1Ec C-terminal E-domain, 24 residues)
- Molecular formula
- C121H199N41O40
- Molecular weight
- ~2,868 g/mol
- Amino acids
- 24
- Sequence
- YQPPSTNKNTKSQRRKGSTFEEHK
- Modification
- The synthetic research peptide corresponds to the free-acid 24-residue E-domain; stabilized analogs substitute D-arginine in the central basic (QRRK) region and amidate the C-terminus to slow proteolysis, and PEGylated forms (PEG-MGF) couple a polyethylene glycol chain to extend circulating half-life.
Mechanism & Target Class
MGF is a synthetic peptide corresponding to the unique C-terminal E-domain of a mechanically inducible IGF-1 splice isoform, a structure generated when inclusion of a short exon-5 insert shifts the reading frame in exon 6 to produce a 24-residue sequence distinct from the predominant systemic isoform. A central, unresolved structural question in the literature is which receptor, if any, this E-domain peptide engages; no dedicated E-peptide binding partner has been definitively identified. The peptide's arginine/lysine-rich polybasic motif has been studied as a potential cell-penetrating and nuclear-localization element, and specific protein interactions (e.g., with 14-3-3 proteins in cardiac cell models) have been characterized.
Storage & Handling
- Lyophilized
- -20°C (colder for long-term); keep desiccated and frozen until use.
- Handling
- Minimize freeze-thaw cycles; protect from light; the unmodified peptide carries multiple basic residues and is handled in aqueous buffers.
Primary Database
References (25)
Reviews
1Vassilakos G, et al. (2014). Hormones (Athens)
- 2
Brisson BK, Barton ER. (2013). Frontiers in Endocrinology
- 3
Matheny RW Jr, Nindl BC, Adamo ML. (2010). Endocrinology
- 4
Goldspink G. (2005). Physiology (Bethesda)
Clinical
5Hameed M, et al. (2004). Journal of Physiology
- 6
Hameed M, et al. (2003). Journal of Physiology
Primary research
7Solís C, et al. (2022). Frontiers in Physiology
- 8
Armakolas A, et al. (2015). Molecular Medicine
- 9
Fornaro M, et al. (2014). American Journal of Physiology-Endocrinology and Metabolism
- 10
Mavrommatis E, Shioura KM, Los T, Goldspink PH. (2013). Molecular and Cellular Biochemistry
- 11
Schlegel W, et al. (2013). PLOS ONE
- 12
Brisson BK, Barton ER. (2012). PLOS ONE
- 13
Deng M, et al. (2011). International Orthopaedics
- 14
Kandalla PK, Goldspink G, Butler-Browne G, Mouly V. (2011). Mechanisms of Ageing and Development
- 15
Armakolas A, et al. (2010). The Prostate
- 16
Stavropoulou A, et al. (2009). Molecular Medicine
- 17
Riddoch-Contreras J, et al. (2009). Experimental Neurology
- 18
Philippou A, et al. (2008). In Vivo
- 19
Carpenter V, et al. (2008). Heart, Lung and Circulation
- 20
Ates K, et al. (2007). FEBS Letters
- 21
Dłużniewska J, et al. (2005). FASEB Journal
- 22
Aperghis M, et al. (2004). Brain Research
- 23
Yang SY, Goldspink G. (2002). FEBS Letters
- 24
McKoy G, et al. (1999). Journal of Physiology
- 25
Yang S, Alnaqeeb M, Simpson H, Goldspink G. (1996). Journal of Muscle Research and Cell Motility
